Back to Awarded Treatment Trials
Awarded Trial: 04T-617
Grant ID
04T-617
Illness
Schizophrenia
Primary Drug/Intervention
Celecoxib
Primary Dosage
200-800 mg/day
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Müller
Sample Size
50
Duration of Study Period for Each Subject
6 weeks
Outcome Measurements
PANSS, CGI, ESRS, Barnes Akathisia Scale.
Results
N/A
Publication
Müller N, Krause D, Dehning S, Musil R, Schennach-Wolff R, Obermeier M, Möller HJ, Klauss V, Schwarz MJ, Riedel M. Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment. Schizophr Res. 2010 Aug;121(1-3):118-24.
Link
http://www.ncbi.nlm.nih.gov/pubmed/20570110
PI Name
Norbert Müller
Degree
MD
Center
Department of Psychiatry
Institution
Ludwig-Maximilians Universitaet
Address
Nussbaumstr. 7
City or Town
Munich
State or Province
N/A
Zip or Postal Code
80336
Country
Germany
Email Address
norbert.mueller@med.uni-muenchen.de